U.S. Physical Therapy (NYSE:USPH) versus Mitesco (OTCMKTS:MITI) Critical Comparison

Mitesco (OTCMKTS:MITIGet Rating) and U.S. Physical Therapy (NYSE:USPHGet Rating) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, earnings, valuation, institutional ownership, risk, analyst recommendations and profitability.

Analyst Ratings

This is a breakdown of recent ratings for Mitesco and U.S. Physical Therapy, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Mitesco 0 0 0 0 N/A
U.S. Physical Therapy 0 0 2 0 3.00

U.S. Physical Therapy has a consensus price target of $121.50, suggesting a potential upside of 52.10%. Given U.S. Physical Therapy’s higher probable upside, analysts clearly believe U.S. Physical Therapy is more favorable than Mitesco.

Valuation and Earnings

This table compares Mitesco and U.S. Physical Therapy’s revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Mitesco $120,000.00 202.27 -$7.92 million ($0.06) -1.79
U.S. Physical Therapy $495.02 million 2.10 $40.83 million $2.93 27.26

U.S. Physical Therapy has higher revenue and earnings than Mitesco. Mitesco is trading at a lower price-to-earnings ratio than U.S. Physical Therapy, indicating that it is currently the more affordable of the two stocks.


This table compares Mitesco and U.S. Physical Therapy’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Mitesco -3,623.87% -4,559.69% -150.67%
U.S. Physical Therapy 7.62% 14.22% 5.80%

Institutional & Insider Ownership

0.1% of Mitesco shares are owned by institutional investors. Comparatively, 98.4% of U.S. Physical Therapy shares are owned by institutional investors. 7.0% of Mitesco shares are owned by company insiders. Comparatively, 1.9% of U.S. Physical Therapy shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Risk and Volatility

Mitesco has a beta of -0.5, meaning that its share price is 150% less volatile than the S&P 500. Comparatively, U.S. Physical Therapy has a beta of 1.32, meaning that its share price is 32% more volatile than the S&P 500.


U.S. Physical Therapy beats Mitesco on 11 of the 13 factors compared between the two stocks.

About Mitesco

(Get Rating)

Mitesco, Inc. operates medical clinics under the The Good Clinic name in North East Minneapolis, the United States. It offers wellness coaching, behavioral health care, episodic care, dermatologic services, and supplements. The company was formerly known as True Nature Holding, Inc. and changed its name to Mitesco, Inc. in April 2020. Mitesco, Inc. is based in Saint Louis Park, Minnesota.

About U.S. Physical Therapy

(Get Rating)

U.S. Physical Therapy, Inc., through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. It operates through two segments, Physical Therapy Operations and Industrial Injury Prevention Services. The company offers industrial injury prevention services, including onsite injury prevention and rehabilitation, performance optimization, post-offer employment testing, functional capacity evaluations, and ergonomic assessments through physical therapists and specialized certified athletic trainers for Fortune 500 companies, and other clients comprising insurers and their contractors. As of December 31, 2021, it operated 591 clinics in 39 states; and managed 35 physical therapy practice facilities. The company was founded in 1990 and is based in Houston, Texas.

Receive News & Ratings for Mitesco Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mitesco and related companies with MarketBeat.com's FREE daily email newsletter.